vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and System1, Inc. (SST). Click either name above to swap in a different company.

System1, Inc. is the larger business by last-quarter revenue ($51.9M vs $37.2M, roughly 1.4× Organogenesis Holdings Inc.). On growth, System1, Inc. posted the faster year-over-year revenue change (-31.3% vs -57.1%). Over the past eight quarters, System1, Inc.'s revenue compounded faster (-21.8% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

System1 is an American Internet advertising company. Formerly known as OpenMail, it was founded in 2013. It describes itself as operating a "Responsive Acquisition Marketing Platform", and cites privacy as one of its principal foci, although it has been criticized for its influence on privacy-focused properties, including search engine Startpage.com. It is headquartered in Marina del Rey, California.

ORGO vs SST — Head-to-Head

Bigger by revenue
SST
SST
1.4× larger
SST
$51.9M
$37.2M
ORGO
Growing faster (revenue YoY)
SST
SST
+25.8% gap
SST
-31.3%
-57.1%
ORGO
Faster 2-yr revenue CAGR
SST
SST
Annualised
SST
-21.8%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ORGO
ORGO
SST
SST
Revenue
$37.2M
$51.9M
Net Profit
$-13.5M
Gross Margin
30.8%
41.0%
Operating Margin
-185.1%
-33.6%
Net Margin
-26.0%
Revenue YoY
-57.1%
-31.3%
Net Profit YoY
4.8%
EPS (diluted)
$-3.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
SST
SST
Q1 26
$37.2M
Q4 25
$225.6M
$51.9M
Q3 25
$150.9M
$61.6M
Q2 25
$101.0M
$78.1M
Q1 25
$86.7M
$74.5M
Q4 24
$126.7M
$75.6M
Q3 24
$115.2M
$88.8M
Q2 24
$130.2M
$94.6M
Net Profit
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$43.7M
$-13.5M
Q3 25
$21.6M
$-18.5M
Q2 25
$-9.4M
$-17.5M
Q1 25
$-18.8M
$-15.9M
Q4 24
$7.7M
$-14.2M
Q3 24
$12.3M
$-23.6M
Q2 24
$-17.0M
$-26.4M
Gross Margin
ORGO
ORGO
SST
SST
Q1 26
30.8%
Q4 25
41.0%
Q3 25
36.9%
Q2 25
35.7%
Q1 25
72.6%
38.2%
Q4 24
75.5%
42.1%
Q3 24
76.7%
28.0%
Q2 24
77.6%
27.6%
Operating Margin
ORGO
ORGO
SST
SST
Q1 26
-185.1%
Q4 25
28.1%
-33.6%
Q3 25
13.7%
-25.3%
Q2 25
-12.5%
-20.4%
Q1 25
-30.9%
-17.6%
Q4 24
8.1%
-15.7%
Q3 24
5.4%
-24.6%
Q2 24
-10.7%
-30.8%
Net Margin
ORGO
ORGO
SST
SST
Q1 26
Q4 25
19.4%
-26.0%
Q3 25
14.3%
-30.1%
Q2 25
-9.3%
-22.4%
Q1 25
-21.7%
-21.3%
Q4 24
6.1%
-18.7%
Q3 24
10.7%
-26.6%
Q2 24
-13.1%
-27.9%
EPS (diluted)
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$0.31
$-3.58
Q3 25
$0.11
$-2.30
Q2 25
$-0.10
$-2.23
Q1 25
$-0.17
$-0.21
Q4 24
$0.05
$-3.41
Q3 24
$0.09
$-3.37
Q2 24
$-0.13
$-3.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
SST
SST
Cash + ST InvestmentsLiquidity on hand
$91.4M
$86.9M
Total DebtLower is stronger
$305.1M
Stockholders' EquityBook value
$30.5M
Total Assets
$520.0M
$405.0M
Debt / EquityLower = less leverage
10.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
SST
SST
Q1 26
$91.4M
Q4 25
$93.7M
$86.9M
Q3 25
$63.7M
$54.6M
Q2 25
$73.1M
$63.6M
Q1 25
$110.0M
$43.9M
Q4 24
$135.6M
$63.6M
Q3 24
$94.3M
$69.1M
Q2 24
$89.9M
$75.7M
Total Debt
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$305.1M
Q3 25
$259.2M
Q2 25
$263.3M
Q1 25
$267.4M
Q4 24
$255.1M
Q3 24
$62.3M
$259.2M
Q2 24
$63.8M
$263.3M
Stockholders' Equity
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$300.1M
$30.5M
Q3 25
$255.1M
$42.7M
Q2 25
$233.2M
$58.2M
Q1 25
$242.9M
$67.2M
Q4 24
$262.9M
$80.3M
Q3 24
$278.5M
$90.3M
Q2 24
$263.5M
$109.4M
Total Assets
ORGO
ORGO
SST
SST
Q1 26
$520.0M
Q4 25
$598.7M
$405.0M
Q3 25
$509.8M
$385.2M
Q2 25
$461.1M
$429.2M
Q1 25
$467.4M
$419.2M
Q4 24
$497.9M
$459.1M
Q3 24
$446.3M
$479.3M
Q2 24
$443.2M
$511.3M
Debt / Equity
ORGO
ORGO
SST
SST
Q1 26
Q4 25
10.01×
Q3 25
6.07×
Q2 25
4.53×
Q1 25
3.98×
Q4 24
3.18×
Q3 24
0.22×
2.87×
Q2 24
0.24×
2.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
SST
SST
Operating Cash FlowLast quarter
$-10.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$39.4M
$-10.6M
Q3 25
$3.1M
$-2.1M
Q2 25
$-32.9M
$24.5M
Q1 25
$-19.9M
$-15.9M
Q4 24
$10.9M
$772.0K
Q3 24
$8.7M
$-5.0K
Q2 24
$4.7M
$10.0M
Free Cash Flow
ORGO
ORGO
SST
SST
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
$-16.0M
Q4 24
$7.6M
Q3 24
$6.1M
$-36.0K
Q2 24
$2.9M
FCF Margin
ORGO
ORGO
SST
SST
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
-21.5%
Q4 24
6.0%
Q3 24
5.3%
-0.0%
Q2 24
2.2%
Capex Intensity
ORGO
ORGO
SST
SST
Q1 26
Q4 25
2.1%
0.0%
Q3 25
1.5%
0.0%
Q2 25
3.6%
0.0%
Q1 25
4.2%
0.1%
Q4 24
2.7%
0.0%
Q3 24
2.2%
0.0%
Q2 24
1.4%
0.0%
Cash Conversion
ORGO
ORGO
SST
SST
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons